Neutrophil-targeted engineered prodrug nanoparticles for anti-inflammation

Jinping Shi, Juan Li*

*此作品的通讯作者

科研成果: 期刊稿件评论/辩论

9 引用 (Scopus)

摘要

Inflammation response is a defense to infection induced by invading pathogen or tissue injury. However, exaggerated inflammation may cause autoimmune or inflammatory disorders, such as acute respiratory distress syndrome, sepsis, stroke and rheumatoid arthritis. Anti-inflammatory agents and anti-cytokine therapy have been developed to inhibit inflammation pathways and neutralize cytokine storm, but the off-targeting delivery and damage in immune system cause systemic severe side-effect. Selective targeting, precise intracellular drug delivery and induced programed apoptosis of neutrophils may be a potential strategy to regulate the inflammatory responses for immune homeostasis. In this commentary, we summarized that the assembled engineering prodrug nanoparticles carrying doxorubicin via pH-responsive bonds that specifically target to and efficiently induce the apoptosis of activated neutrophils for anti-inflammation with high therapeutic efficacy and no systemically toxicity could be a promising strategy for neutrophil-mediated diseases.

源语言英语
页(从-至)9828-9831
页数4
期刊FASEB Journal
34
8
DOI
出版状态已出版 - 1 8月 2020

指纹

探究 'Neutrophil-targeted engineered prodrug nanoparticles for anti-inflammation' 的科研主题。它们共同构成独一无二的指纹。

引用此